Tablets

Feb 02, 2016 at 18:13 | Source: PTI
"The company's US subsidiary Lupin Pharmaceuticals Inc has launched its Metformin HCl extended release tablets in the strengths of 500 mg and 1,000 mg," Lupin said in a BSE filing.
Feb 02, 2016 at 14:58 | Source: Moneycontrol.com
Lupin announced today that its US subsidiary, Lupin Pharmaceuticals Inc. has launched its Metformin HCl ER Tablets, 500 mg and 1000 mg to market a generic equivalent of Santarus Inc.s Glumetza HCl ER Tablets, 500 mg and 1000 mg.
Feb 01, 2016 at 18:36 | Source: PTI
Streaming of content can be done through wireless mode to wi-fi enabled personal devices such as smartphones, tablets and laptops.
Jan 29, 2016 at 14:14 | Source: Moneycontrol.com
Unichem Laboratories has received Final ANDA approval from USFDA for Alfuzosin Hydrochloride Extended-Release Tablets USP.
Jan 27, 2016 at 15:12 | Source: PTI
The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Voriconazole tablets in the strengths of 50 mg and 200 mg, Aurobindo Pharma said in a statement.
Jan 27, 2016 at 12:30 | Source: Moneycontrol.com
Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Voriconazole Tablets, 50 mg and 200 mg. This product is expected to be launched in Q4 FY15-16.
Jan 19, 2016 at 09:08 | Source: PTI
Through the deal, Strides will buy Johnson and Johnson's seven brands in dermatology, anti-emetic and pain management segments. The brands Strides will acquire include Otogesic ear drops, Ethnorub ointment and Stugil tablets.
Jan 14, 2016 at 22:03 | Source: PTI
This nationwide Class II recall is on account of "the original manufacturer's recall, in which the firm did not adequately investigate customer complaints," the United States Food and Drug Administration (USFDA) said in its latest Enforcement Report.
Jan 11, 2016 at 14:57 | Source: PTI
The company has received the final nod from the US Food and Drug Administration (USFDA) to manufacture and market Norethindrone Acetate tablets in the strength of 5 mg, Aurobindo Pharma said in a statement.
Jan 11, 2016 at 13:19 | Source: Moneycontrol.com
Aurobindo Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Norethindrone Acetate Tablets USP, 5mg.
Messages on Tablets »

madrasan

Silver Member

1 Followers

Shasun Pharma  

a license to sell a generic version of Renvela (sevelamer carbonate) 800-mg tablets beginning March 16, 2014. Impax can also sell oral suspension versions of Renvela and Renagel (sevelamer hydrochloride) beginning September 16, 2014.

12.48 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

11586 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding the press release dated July 08, 2014 titled,"Glenmark Generics receives final ANDA approval for Telmisartan Tablets."

12.41 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

11586 Followers

Glenmark  

Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from the United States Food and Drug Administration (US FDA) for Telmisartan Tablets. Glenmark will commence distribution of the product immediately.

12.04 PM Jul 8th 2014

BSE/NSE Announcer

Platinum Member

11586 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets" Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from

12.04 PM Jul 8th 2014

phs25

Gold Member

9 Followers

Glenmark  

Glenmark Generics receives final ANDA approval for Telmisartan Tablets | 07/08/14 12:01 Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets

12.03 PM Jul 8th 2014

aindia

Silver Member

207 Followers

Ybrant Digital  

% growth for the first time since 2004, when ad spending increased 6.7%. Mobile will lead this year’s rise in total media ad spending in the US, and advertisers will spend 83.0% more on tablets and smartphones than they did in 2013—an increase of $8.04 billion. By the end of this year, mobile

7.34 PM Jul 2nd 2014

Web Messenger

Platinum Member

333922 Followers

Mobile Tele  

Source:VC Circle - Samsung-Galaxy-Tab-S After unveiling the same last month, Samsung has now launched its Galaxy Tab S range of tablets in the Indian market. The tablets are available in 8.4 and 10.5 inch display screen sizes and according to the company, these are the ...

3.16 PM Jul 2nd 2014

Web Messenger

Platinum Member

333922 Followers

Mobile Tele  

Source:Money Rediff News Report - Sony's flagship tablet - the Xperia Z2 Tablet - after going on sale in some parts of the world, has now become available in India at an online retailer at a price of Rs. 49,990 for its 4G LTE variant. The tablet is also listed on the official website

3.16 PM Jul 2nd 2014

Web Messenger

Platinum Member

333922 Followers

Mobile Tele  

Source:Money Rediff News Report - Korean electronics giant Samsung today launched its new tablet 'Tab S' for Rs 37,800 onwards, to further strengthen its position in the Indian market. The device will be available in two screen sizes - 8.4 inch and 10.5 inch - priced at Rs 37,800 and

3.16 PM Jul 2nd 2014

Web Messenger

Platinum Member

333922 Followers

News Now  

Source:Economic Times - Hybrids and Detachables When Microsoft launched Windows 8 with a touch-optimized interface, a number of manufacturers launched hybrid and detachable devices that offered the benefit of a traditional laptop as well as a tablet. These hybrids are easy to carry around, have

3.12 PM Jul 2nd 2014

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.